Pharmaceutical Investing AMAG Pharmaceuticals Announces Topline Results From the PROLONG Trial Evaluating Makena
Pharmaceutical Investing AMAG Pharmaceuticals Acquires Orphan Drug Candidate for Treatment of Severe Preeclampsia
